Literature DB >> 28421363

Response to Dr. Hawkes letter regarding HPV vaccine serious adverse events.

Manuel Martínez-Lavín1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28421363     DOI： 10.1007/s10067-017-3630-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Suspected side effects to the quadrivalent human papilloma vaccine.

Authors:  Louise Brinth; Ann Cathrine Theibel; Kirsten Pors; Jesper Mehlsen
Journal:  Dan Med J       Date:  2015-04       Impact factor: 1.240

2.  Response to "Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial".

Authors:  David Hawkes
Journal:  Clin Rheumatol       Date:  2017-03-25       Impact factor: 2.980

3.  Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial.

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2017-02-16       Impact factor: 2.980

4.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

5.  HPV vaccination syndrome. A questionnaire-based study.

Authors:  Manuel Martínez-Lavín; Laura-Aline Martínez-Martínez; Paola Reyes-Loyola
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 3.650

6.  Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®.

Authors:  Rebecca E Chandler; Kristina Juhlin; Jonas Fransson; Ola Caster; I Ralph Edwards; G Niklas Norén
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.